Rodd Friedman serves as Executive at ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/, where they oversee executive responsibilities. Since joining the company, Rodd Friedman has executed 8 insider transactions totaling $390.6K, demonstrating a bullish approach to their equity position. Their most recent transaction on Nov 18, 2019 involved receiving (via award) 3,178 shares valued at $7.5K.
Rodd Friedman currently holds 39,911 shares of ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ (HRT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Rodd Friedman has been a net buyer of HRT stock. They have purchased $313.2K and sold $77.4K worth of shares.
Rodd Friedman's most recent insider trade was on Nov 18, 2019, when they sold 3,178 shares at $2.36 per share.
Get notified when new Form 4 filings are submitted
| $2.30 |
| Discretionary |
| May 15, 2019 | MICR | $7.5K | Award | 2,941 | $2.55 | Discretionary |
| Feb 15, 2019 | MICR | $7.5K | Award | 3,000 | $2.50 | Discretionary |
| Aug 31, 2015 | HRT | $297.4K | Purchase | 46,111 | $6.45 | Discretionary |
| Aug 31, 2015 | HRT | $77.4K | Sale | 13,340 | $5.80 | Discretionary |
| Aug 24, 2015 | HRT | $13.2K | Purchase | 2,133 | $6.21 | Discretionary |
| Jun 16, 2015 | HRT | $2.6K | Purchase | 400 | $6.38 | Discretionary |